Zafar Latif in Daytona Bch, Florida

Home Florida Daytona Bch

Zafar Latif has Hematology/oncology as his primary medical specialty. Their primary office is: 303 N Clyde Morris Blvd in Daytona Bch, Florida. There are 4 additional office locations for Zafar Latif that can be viewed towards the end of their profile.

They're a part of the: Halifax Healthcare Systems Inc medical group which has around 272 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2004 (around 20 years of experience). They are listed as doing telehealth appointments.

Zafar Latif Office Phone and Directions

Zafar Latif
Halifax Healthcare Systems Inc
303 N Clyde Morris Blvd
Daytona Bch, Florida 32114
-

Patient Ratings
Please rate your experience with Zafar Latif below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Enter a starting address:

Healthcare Info for Zafar Latif

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2004
The Primary Medical Specialty for Zafar Latif is listed as: Hematology/oncology
Approximate Years of Experience: 20
PAC (PECOS ID)#: 6608023270
NPI #: 1861627663
NPI Created On: 05/21/2009
NPI Last Updated Listed as: 01/30/2014
Primary Taxonomy Code: 207RH0003X
License Number:
113492
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Florida Health Care Plans
Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Urdu, English.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788763763

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813014111

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HEMATOLOGY

Name of Drug #1: TASIGNA

Open Associated Drug #1: 0078-0526-51

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813014103

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813014107

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813014115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813014119

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;KP31550;KPConcur;11179479

Record ID:: 844416853

Being Disputed:: No

Product Related: Yes

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2781490;EPRINTS;11179479

Record ID:: 845875541

Being Disputed:: No

Product Related: Yes

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 851408267

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Lenvima

Open Associated Drug #1: 62856-710-30

Additional Office Locations

1. Halifax Healthcare Systems Inc
1185 Dunlawton Ave
Port Orange, FL 32127
Suite 105
Group Members: 272

Phone: -

Enter a starting address:

2. Halifax Healthcare Systems Inc
1041 Dunlawon Ave
Port Orange, FL 32127
Group Members: 272

Phone: -

Enter a starting address:

3. Halifax Healthcare Systems Inc
401 Palmetto St
New Smyrna Beach, FL 32168
Group Members: 272

Phone: -

Enter a starting address:

4. Halifax Healthcare Systems Inc
1688 W Granada Blvd
Ormond Beach, FL 32174
Group Members: 272

Enter a starting address:

Hematology/oncology Professionals in Daytona Bch

1.
Boon Chew MD

303 N Clyde Morris Blvd
Daytona-bch, FL
Halifax Healthcare Systems Inc

2.
Cesar De Las Casas MD

303 N Clyde Morris Blvd
Daytona-bch, FL
Halifax Healthcare Systems Inc

3.
Thuy Le

303 N Clyde Morris Blvd
Daytona-bch, FL
Halifax Healthcare Systems Inc

4.
Tabitha Townsend

303 N Clyde Morris Blvd
Daytona-bch, FL
Halifax Healthcare Systems Inc

5.
Richard Weiss

303 N Clyde Morris Blvd
Daytona-bch, FL
Halifax Healthcare Systems Inc

Providers in Halifax Healthcare Systems Inc

1.Jose Abando Md

303 N Clyde Morris Blvd
Daytona Bch Fl 32114-2709
Halifax Healthcare Systems Inc
Hospitalist

2.Jose Abando Md

1041 Dunlawon Ave
Port Orange Fl 32127-7968
Halifax Healthcare Systems Inc
Hospitalist

3.John Abbensetts Md

303 N Clyde Morris Blvd
Daytona Bch Fl 32114-2709
Halifax Healthcare Systems Inc
Critical Care (intensivists)

4.Abdul Ahmed

303 N Clyde Morris Blvd
Daytona Bch Fl 32114-2709
Halifax Healthcare Systems Inc
Family Practice

5.Shakil Ahmed Md

303 N Clyde Morris Blvd
Daytona Bch Fl 32114-2709
Halifax Healthcare Systems Inc
Internal Medicine

6.Shakil Ahmed Md

3300 E Halifax Crossing Blvd
Deltona Fl 32725-2911
Halifax Healthcare Systems Inc
Internal Medicine

View all 272 members of Halifax Healthcare Systems Inc medical group